123 related articles for article (PubMed ID: 29587204)
1. Leukotriene D4 induces cellular senescence in osteoblasts.
Wei J; Chen S; Guo W; Feng B; Yang S; Huang C; Chu J
Int Immunopharmacol; 2018 May; 58():154-159. PubMed ID: 29587204
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of cysteinyl leukotriene receptor 1 (cysLTR1) by montelukast suppresses cell senescence of chondrocytes.
Song W; Zhang Y; Wang J; Ma T; Hao L; Wang K
Cytokine; 2018 Mar; 103():83-89. PubMed ID: 29331588
[TBL] [Abstract][Full Text] [Related]
3. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
Wang X; Lu Y; Zhang W; Wei E; Fang S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
6. Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro.
Yu SY; Zhang XY; Wang XR; Xu DM; Chen L; Zhang LH; Fang SH; Lu YB; Zhang WP; Wei EQ
Acta Pharmacol Sin; 2014 Jan; 35(1):33-40. PubMed ID: 24141567
[TBL] [Abstract][Full Text] [Related]
7. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
[TBL] [Abstract][Full Text] [Related]
9. Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation.
Kachi K; Kato H; Naiki-Ito A; Komura M; Nagano-Matsuo A; Naitoh I; Hayashi K; Kataoka H; Inaguma S; Takahashi S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299067
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of cysteinyl leukot-riene receptor 1 (cysLT1R) by montelukast regulates differentiation of MC3T3-E1 cells under overloaded mechanical environment.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):995-1001. PubMed ID: 29032198
[TBL] [Abstract][Full Text] [Related]
11. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
12. Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells.
Satapathy SR; Sjölander A
Cancer Lett; 2020 Sep; 488():50-62. PubMed ID: 32474153
[TBL] [Abstract][Full Text] [Related]
13. The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide.
Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
Int Immunopharmacol; 2018 Feb; 55():193-197. PubMed ID: 29268191
[TBL] [Abstract][Full Text] [Related]
14. [Leukotriene D4 activates BV2 microglia in vitro].
Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
[TBL] [Abstract][Full Text] [Related]
15. Allergen challenge-induced changes in bone-marrow responses to leukotriene D
Masid-de-Brito D; Vieira BM; de Souza CC; Silva F; Gaspar-Elsas MIC; Xavier-Elsas P
Immunopharmacol Immunotoxicol; 2020 Jun; 42(3):199-210. PubMed ID: 32122206
[No Abstract] [Full Text] [Related]
16. Cysteinyl leukotrienes synergize with growth factors to induce proliferation of human bronchial fibroblasts.
Yoshisue H; Kirkham-Brown J; Healy E; Holgate ST; Sampson AP; Davies DE
J Allergy Clin Immunol; 2007 Jan; 119(1):132-40. PubMed ID: 17208594
[TBL] [Abstract][Full Text] [Related]
17. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
Kanaoka Y; Maekawa A; Austen KF
J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Matsuyama M; Hayama T; Funao K; Kawahito Y; Sano H; Takemoto Y; Nakatani T; Yoshimura R
Oncol Rep; 2007 Jul; 18(1):99-104. PubMed ID: 17549353
[TBL] [Abstract][Full Text] [Related]
19. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
20. Lipid mediator Leukotriene D
Dholia N; Yadav UCS
Prostaglandins Other Lipid Mediat; 2018 May; 136():55-63. PubMed ID: 29751150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
